Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bladder cancer
Pharma
Gilead pulls Trodelvy in bladder cancer after trial flop
Gilead said it will pull Trodelvy's accelerated approval in bladder cancer after consultation with the FDA.
Angus Liu
Oct 18, 2024 10:18am
Ferring cuts ribbon at new gene therapy manufacturing hub
Oct 3, 2024 12:07pm
AZ's perioperative Imfinzi extends life in bladder cancer type
Sep 15, 2024 10:30am
AstraZeneca's Imfinzi counts a trial win and a miss
Jun 25, 2024 11:00am
Pfizer sees 8 blockbuster cancer drugs from each focus area
Jun 13, 2024 12:45pm
Gilead's Trodelvy suffers double whammy
May 30, 2024 6:20pm
